STUMPTOWN STRATEGIES for PRIME THERAPEUTICS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Introduction to Prime to Members of the 118th Congress Monitoring PBM Legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| BLAIR LARKINS | Staff Assistant, Rep. Greg Walden (2005-2006); Executive Assistant, Rep. Greg Walden (2006-2011) |
Health Issues HCR
Introduction to Prime to new Members of the 118th Congress Monitoring PBM Legislation Senate Finance Committee PBM Framework - Delinking S.1339 - The Pharmacy Benefit Manager Reform - Delinking H.R. 3561 - Patient Act - Transparency Requirements & Spread Pricing H.R. 4507 - Health DATA Act - Provisions related to plan fiduciaries access to data H.R.5378 - The Lower Cost More Transparency Act - Sections 105, 106, 109, 110, 202, 401, 402 & 403-provisions related to PBM transparency and disclosure
| Lobbyist | Covered position, as disclosed |
|---|---|
| BLAIR LARKINS | Staff Assistant, Greg Walden 2005-2006, Executive Assistant, Greg Walden 2006-2001 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.